These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7595383)

  • 1. Passage of Japanese encephalitis virus in HeLa cells results in attenuation of virulence in mice.
    Cao JX; Ni H; Wills MR; Campbell GA; Sil BK; Ryman KD; Kitchen I; Barrett AD
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2757-64. PubMed ID: 7595383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
    Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
    J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2.
    Yang D; Li XF; Ye Q; Wang HJ; Deng YQ; Zhu SY; Zhang Y; Li SH; Qin CF
    Vaccine; 2014 May; 32(23):2675-81. PubMed ID: 24709585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.
    Yu Y
    Vaccine; 2010 May; 28(21):3635-41. PubMed ID: 20226891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of nucleotide and deduced amino acid sequence of the 5' non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives.
    Ni H; Burns NJ; Chang GJ; Zhang MJ; Wills MR; Trent DW; Sanders PG; Barrett AD
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1505-10. PubMed ID: 8207417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease.
    Chambers TJ; Droll DA; Jiang X; Wold WS; Nickells JA
    Virology; 2007 Sep; 366(1):51-61. PubMed ID: 17521693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14.
    Ni H; Chang GJ; Xie H; Trent DW; Barrett AD
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():409-13. PubMed ID: 7844560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic characterization of nine wild-type Taiwanese isolates of Japanese encephalitis virus as compared with two vaccine strains.
    Wu SC; Lian WC; Hsu LC; Wu YC; Liau MY
    Virus Res; 1998 May; 55(1):83-91. PubMed ID: 9712514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
    Gromowski GD; Firestone CY; Whitehead SS
    J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.
    Monath TP; Levenbook I; Soike K; Zhang ZX; Ratterree M; Draper K; Barrett AD; Nichols R; Weltzin R; Arroyo J; Guirakhoo F
    J Virol; 2000 Feb; 74(4):1742-51. PubMed ID: 10644345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area.
    Wills MR; Sil BK; Cao JX; Yu YX; Barrett AD
    Vaccine; 1992; 10(12):861-72. PubMed ID: 1455912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of wild-type yellow fever virus by passage in HeLa cells.
    Barrett AD; Monath TP; Cropp CB; Adkins JA; Ledger TN; Gould EA; Schlesinger JJ; Kinney RM; Trent DW
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2301-6. PubMed ID: 2230735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants.
    Cecilia D; Gould EA
    Virology; 1991 Mar; 181(1):70-7. PubMed ID: 1704661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in haemagglutination activity and electrophoretic mobility of E protein between the parent SA14 and attenuated vaccine SA14-14-2 strains of Japanese encephalitis virus.
    Lee T; Komiya T; Watanabe K; Aizawa C; Hashimoto H
    Acta Virol; 1995 Apr; 39(2):109-11. PubMed ID: 7676935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants.
    Ni H; Barrett AD
    Virology; 1998 Feb; 241(1):30-6. PubMed ID: 9454714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus.
    Dunster LM; Wang H; Ryman KD; Miller BR; Watowich SJ; Minor PD; Barrett AD
    Virology; 1999 Sep; 261(2):309-18. PubMed ID: 10497116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus.
    Liu X; Zhao D; Jia L; Xu H; Na R; Ge Y; Liu S; Yu Y; Li Y
    Vaccine; 2018 Jul; 36(31):4650-4656. PubMed ID: 29954631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasiveness.
    Ni H; Barrett AD
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1449-55. PubMed ID: 8757986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the live-attenuated Japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo.
    Yun SI; Song BH; Polejaeva IA; Davies CJ; White KL; Lee YM
    J Gen Virol; 2016 Oct; 97(10):2575-2591. PubMed ID: 27498826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.